Search results
Pfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dose - Triangle Business...
The Business Journals· 12 hours agoThe U.S. Food and Drug Administration has approved a gene therapy developed by Pfizer and...
Pfizer’s First Gene Therapy Gets Approval for Clotting Disorder
Bloomberg· 3 days agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine...
Moderna, Pfizer/BioNTech set for UK court clash over COVID jab patents
Medical Xpress· 6 days agoA row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday...
US FDA approves Pfizer's gene therapy for rare bleeding disorder
Reuters via AOL· 3 days ago(Reuters) -The U.S. Food and Drug Administration approved Pfizer's gene therapy for hemophilia B on...
The Motley Fool: Pfizer offers a pfat 6.4% dividend
Dallas Morning News· 24 hours agoShares of Pfizer were recently down more than 35% over the past year — in part because the market’s enthusiasm for its COVID-19 vaccine Comirnaty and...
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
Motley Fool via Yahoo Finance· 1 day agoHowever, such stocks exist. Here are three high-yield dividend stocks that could soar 22% to 49%...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 6 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 4 days ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
A Fed meeting, jobs report, and more Big Tech earnings: What to know this week
Yahoo Finance· 2 hours ago...Etsy (ETSY), Kraft Heinz (KHC), Marriott International (MAR), Mastercard (MA), Norwegian Cruise...
Pfizer confirms COVID pill's results, potency versus omicron
AOL· 3 days agoPfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron...